10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
In the realm of antimicrobials, antifungal agents stand as a specialized arsenal against fungal pathogens. Among the diverse classes of antifungal drugs, allylamines such as terbinafine disrupt fungal cell membrane synthesis by inhibiting squalene epoxidase. This class is particularly effective against dermatophyte infections like ringworm. Flucytosine, an antimetabolite, interferes with nucleic acid synthesis in fungi. It is often used in combination with other antifungal drugs for systemic mycoses. Griseofulvin, another unique agent, disrupts fungal cell division by targeting microtubules, making it effective against dermatophyte infections of the skin, hair, and nails. As with any antimicrobial, antifungal agents require careful consideration of their side effects, drug interactions, and the specific fungal species causing the infection. The continuous development of novel antifungal agents remains imperative to stay ahead in the ongoing battle against fungal infections.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States